Monday, March 03, 2025 | 12:33 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Divis Laboratories to spend Rs 15 billion on expansion by next year

The company said it would be investing Rs 6 billion each on its Unit-2 at the Vizag SEZ in Andhra and Unit-1 of its Nalgonda SEZ in Telangana

v
Premium

Pharma Stocks, Sun Pharma, Cadila, Cipla

B Dasarath Reddy Hyderabad
Divis Laboratories, maker of active pharmaceutical ingredients (APIs) and drug intermediates, will spend Rs 15 billion to expand existing facilities over the next 15 months.

The company said it would be investing Rs 6 billion each on its Unit-2 at the Vizag SEZ in Andhra and Unit-1 of its Nalgonda SEZ in Telangana. And, another Rs 3 billion for de-bottlenecking at Vizag. All the work is expected to be complete by end-December 2019. The company currently operates four multipurpose manufacturing facilities, from these two sites. 

The management said the investment was to cater for the rising opportunities in generic and

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in